innovation are necessarily at odds with each other. Although intuitively appealing, the argument that drug regulation negatively … than decreasing the expected returns to innovation, this aspect of regulation contributes to the value of new drugs and may … actually encourage innovation. This point has largely been absent from most cost-benefit analyses of drug regulation, yet …
